Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
Australia
Westmead Hospital, Westmead, New South Wales Wollongong Hospital, Wollongong, New South Wales Austin Hospital, Heidelberg, Victoria China
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian Henan Cancer Hospital, Zhengzhou, Henan Hunan Cancer Hospital, Changsha, Hunan The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital), Jinan, Shandong Zhejiang Cancer Hospital, Hangzhou, Zhejiang